B. Riley Is Buying This Drugmaker After Its Sell-Off

GTHX shares are trying to break through a former area of resistance

by Josh Selway

Published on Feb 11, 2019 at 2:15 PM

Cancer treatment specialist G1 Therapeutics (NASDAQ:GTHX) has seen its stock price decline precipitously since its Sept. 11 peak of $69.57, bottoming at $15.21 on Dec. 21 following a bear gap sparked by disappointing trial data from the company's cancer drug, trilaciclib. Since then, the shares have been steadily climbing the charts, trading up 2.3% at $21.73 today, on pace for their highest close since that gap, thanks to another bullish analyst note.

Specifically, B. Riley began coverage on GTXH with a "buy" rating and $55 price target, representing a 153% runway from current levels. This upbeat attention only mirrors the broader sentiment seen across the Street, where six of seven analysts say to buy the security. What's more, the average 12-month price target is all the way up at $69.50.

On a more negative note, short interest has been increasing on the equity since early December. The 2.37 million shares held by short sellers equated to 8.8% of the float, or 6.7 days' worth of buying power, based on average daily trading volumes.

Looking closer at the charts, G1 Therapeutics stock is attempting to push past its 40-day moving average, set to close above the trendline again today. The shares' rally attempts back in November and December were neatly blocked by this moving average.

gthx stock price

SAGE Therapeutics Stock Hot Ahead of Earnings
The drug name is scheduled to report on Tuesday
Bear Signal Flashing for This Healthcare Stock Before Earnings
At least four analysts have issued price-target cuts on the stock this week
Signal Says This Retail Stock's on Sale
The shares pulled back this week on news of a Levi Strauss IPO
START YOUR DAY SMARTER.

Get Schaeffer's pre-market news bulletin every morning before the bell rings.
It's free to sign up.


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


IRA/401K Investment Guide: 2019 Stock Market Crash
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.
3 of Today's Worst Nasdaq Stocks
The stocks are sitting out today's rally in the broader equities market
2019 Rally Continues for Stock Market
The Nasdaq is eyeing its longest weekly win streak since 2016
How American Lithium Tech May Be Poised for 614% Growth
A new lithium technology could change the face of lithium production forever.